|
|
Letter from the CEO of BioNTX 2025 BIO International Convention |
|
Dear Members, Friends and Partners,
As we prepare to engage with the global life sciences community at this week’s BIO International Convention, it is my pleasure to introduce this special edition of the BioNTX Newsletter. Our mission remains constant: to shine a spotlight on the strength, depth, and vibrancy of the North Texas life sciences ecosystem—an ecosystem that is deeply interconnected with the broader Texas, southwest region and international Bioscience sector.
This year, BioNTX is proud to join fellow Texas organizations at the BioTexas Pavilion (Booth #2665), anchoring the DFW Corner alongside the Dallas Regional Chamber, BioLabs at Pegasus Park, and representatives from cities across our metroplex. This regional collaborative presence is more than a shared exhibit—it symbolizes a region-wide commitment to innovation, economic development, and strategic partnerships that propel our ecosystem forward.
The BIO International Convention stands as the premier global gathering for biotechnology leaders from over 30 countries, offering unparalleled opportunities for networking, dealmaking, and collaboration. Our participation is part of a comprehensive strategy to promote North Texas as a thriving hub of life sciences innovation, fostering new partnerships and amplifying our voice on the international stage.
As we celebrate Texas’ remarkable ecosystem—home to thousands of life science companies, world-class research institutions, and the largest medical center on the planet—we recognize the tremendous room for growth and impact ahead. Events like the BIO Convention and our own iC³ Life Science Summit, the southwest region’s flagship gathering, are vital pieces of the larger Bio puzzle, positioning at large as critical contributors to the future of biotechnology and healthcare innovation.
I invite you to explore the stories and insights in this newsletter, designed to bring you closer to the people, projects and partnerships driving our sector’s momentum. And while at the BIO International Convention, please visit us at Booth #2665 to connect with the innovators shaping Texas’ future in biotech.
Together, we are building a vibrant, connected ecosystem—one that is poised to lead on the national and international stage.
Warmest Regards, |
|
Discover Texas Innovation at BIO International Convention, Booth #2665 |
|
|
Meet us at BIO 2025 |
|
|
|
Join BioTexas for a trip with light bites, beer, and cocktails to network with industry leaders and communities that make Texas a leading life science destination.
June 17th | Boston, MA |
|
|
Join BioTexas for a casual breakfast in the Seaport District, just a few minutes from the Boston Convention Center.
June 18th | Boston, MA |
|
|
GROUNDBREAKING NEWS |
|
Renibus Therapeutics Receives Orphan Drug Designation for Veverimer |
|
|
Renibus Therapeutics® has been granted Orphan Drug Designation by the FDA for Veverimer, a treatment for anti-glomerular basement membrane (anti-GBM) disease—an ultra-rare autoimmune condition that causes acute kidney failure. The designation offers development incentives including tax credits, user fee exemptions, and potential seven-year market exclusivity. Veverimer targets key drivers of anti-GBM and other complement-mediated kidney diseases and is being advanced to address areas of high unmet need. |
|
Lantern Pharma Reports Complete Response in Phase 2 HARMONIC™ Trial |
|
|
Lantern Pharma Inc., a clinical-stage oncology company using AI to develop precision cancer therapies, reported a durable complete response in a 70-year-old patient with advanced non-small cell lung cancer in its Phase 2 HARMONIC™ trial. After prior treatments failed, the patient showed significant tumor reduction and complete response by early 2025, with sustained benefits nearly two years later. |
|
Signify Bio Announces Initial Financing to Advance In Situ Protein Therapeutics |
|
|
Signify Bio, a pioneering biotechnology company developing in situ protein therapeutics, has announced the close of its oversubscribed initial financing round. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the venture capital arm of the American Cancer Society. Signify Bio’s platform integrates proprietary non-viral delivery systems with nucleic acid payloads to enable targeted control of protein production, secretion, and localization within the human body. |
|
How BioNTX is Fueling Life Science Innovation |
|
|
|
What does it take to turn an emerging region into a thriving biotech hub?
In this episode of Transfer Files, Kathleen Otto-Rosenblum, CEO of BioNTX, shares how she is leading the charge to build a connected, collaborative life sciences ecosystem in North Texas. Drawing from her experience building biotech networks on the East Coast, she discusses BioNTX’s role in accelerating early-stage innovation through commercialization support, investor access, and strategic partnerships. She also highlights a growing collaboration with the Federal Laboratory Consortium, focused on unlocking underused federal research and strengthening trust in government-funded science. Through her lens, we see how trusted relationships and thoughtful infrastructure are powering the next wave of biotech growth. |
|
INTRODUCING: INSIDE INNOVATION BY ERIC B. MOORE, CHIEF COMMUNICATIONS OFFICER OF BIONTX |
|
Welcome to Inside Innovation—the narrative thread that runs through the heart of North Texas’ life sciences ecosystem. This section goes beyond headlines to share the stories behind the science, inside the science, and because of the science—highlighting the breakthroughs, the challenges, and the people driving innovation across our region. Here, you will find the depth and perspective that bring our ecosystem to life, the way only BioNTX can. Whether it is a behind-the-scenes look at a new partnership, a founder's unfiltered journey, or reflections on what’s emerging across our innovation landscape, Inside Innovation delivers the depth, dimension, and dialogue you have come to expect from BioNTX.
|
|
Fighting for the Future: Voices Driving Rare Disease Innovation |
|
|
(from left to right) Amber Freed of SLC6A1 Connect, Kimberly Fry of SLC6A1 Connect, Whitney Feldman, MHA of Psychiatric Medical Care and Eric B. Moore of BioNTX |
|
One of the most rewarding parts of my role at BioNTX is the opportunity to meet and support people who are not only remarkable in their efforts—but who redefine what’s possible through sheer will, resilience, and purpose.
Recently, I had the privilege of spending time with Amber Freed, Kimberly Fry, and Whitney Feldman of SLC6A1 Connect—three powerful women who are leading a charge few could imagine, let alone carry. Their mission: to find a cure for SLC6A1, a rare and devastating neurological disorder that affects children with seizures, cognitive impairments, and developmental delays. These children often cannot speak for themselves—and so their families become their voices, their scientists, their fundraisers, their fighters.
The event, Rare Disease, Real Impact: How a Nameless Disease Created a Community, hosted by the Biotech Club at UT Southwestern and supported by Lyda Hill Philanthropies, BioLabs, and the UTSW Graduate School of Biomedical Sciences, showcased exactly what we mean when we say innovation is personal. Together with Dr. Steven Gray, who is developing gene replacement therapy at UTSW, these leaders are pushing the boundaries of what treatment and hope can look like.
Their work reminded me of the communities I have collaborated with throughout West Africa—people whose daily lives are shaped by resilience, whose solutions are born of necessity, and whose courage often inspires far beyond what the world sees. Whether on the continent or here in North Texas, the core elements remain the same: human resilience, community, and innovation are the thread that connects us across backgrounds and borders. They remind us that progress is not just a scientific endeavor—it is an emotional one. And often, the people most inspired to act are those who’ve simply heard the echo of someone else’s courage.
At BioNTX, our mission is to amplify those voices—from early-stage companies breaking new scientific ground, to academic labs pushing the frontier, to committed philanthropists and visionary investors, and yes, to families who never imagined becoming experts in science or policy but who do so out of love and necessity.
Amber, Kimberly, and Whitney are not just advocates. They are strategists, connectors, and relentless champions for change. Their work is proof that not all innovation starts in a lab—sometimes it begins with a parent’s question: What would you do if it were your child?
We are proud to support, spotlight, and stand beside leaders like them. Because every breakthrough begins with someone who refuses to accept the impossible. |
|
EVENT RECAP |
|
Shaping the Future Life Science Workforce in North Texas |
|
|
|
|
|
(from left to right) Grant Carter, MSOL of Carter, Inc., Jennifer Cowley, PhD, FAICP of UT Arlington, Rebecca Cunningham, PhD of UNT Health Science Center, Monica Valenta of Northwest ISD, Eric Danielson, AICP of NexPoint, Eniola Ashafa, MS of AstraZeneca, Karen Buechman of Plano ISD, Baley Reeves, PhD of National Center for Therapeutics Manufacturing, and Eric B. Moore of BioNTX |
|
The BioNTX Facilities Advisory Committee hosted an engaging session at the Texas Research Quarter, bringing together voices from manufacturing, higher education, and K–12 STEM education. The focus: how we’re shaping the education and training infrastructure to support the next generation of life science professionals. This cross-sector discussion explored how collaboration is aligning classroom learning with industry needs—positioning North Texas as a national hub for biomanufacturing and biotech innovation. |
|
First Annual Scientific Research Innovation Showcase and Supplier Expo at Pegasus Park |
|
|
|
|
BioNTX and Avantor recently brought together leading innovators and vendors for an engaging event focused on cutting-edge lab solutions. Attendees explored a wide range of technologies supporting every phase of research, development, and production—spanning biotech, pharma, and other life science sectors.
From hands-on demos to meaningful conversations with industry leaders, the event offered valuable insights into how today’s tools are shaping the future of research. Thank you to all who joined us to connect, learn, and move science forward. |
|
Summer’s Last BIO BREAK Fort Worth Sparks Collaboration Across the Life Science Sector |
|
|
|
BioNTX’s final BIO BREAK Fort Worth event of the summer brought together a diverse group of life science professionals from industry, academia, and education to connect and engage in meaningful conversations. The gathering provided a platform for sharing insights, addressing challenges, and exploring opportunities within the North Texas biotech ecosystem. Attendees used the event to strengthen existing relationships, form new collaborations, and support ongoing efforts to advance the region’s position as a growing hub for life science innovation and workforce development. |
|
BIONTX PRESENTS: COMING SOON |
|
Leveraging Australia’s Advantages to Accelerate Early-Phase Clinical Trials June 25, 2025 |
|
|
|
Join BioNTX as we welcome an Australian delegation to Dallas. Discover how Australia’s fast regulatory process, quality systems, and cost incentives make it a top choice for early-phase clinical trials. Learn how engaging with Australia can accelerate your clinical trials.
Thank you for your support |
|
|
Chronic Disease Day Gathers Leaders and Patient Advocates July 10, 2025 |
|
|
|
|
BioNTX and Good Days invite you to an exclusive luncheon symposium on Thursday, July 10 at Pegasus Park, bringing together senior leaders in biotech and healthcare, patient advocates, and key community stakeholders.
This gathering will spotlight urgent federal priorities in chronic illness care, unveil new regional partnerships, and explore bold opportunities to expand access to breakthrough treatments. |
|
Reconnect: An Evening for the Life Sciences Community July 29, 2025 |
|
|
|
|
The way we work has changed—but our need to connect, collaborate, and grow has not. Join fellow professionals from biotech, pharma, and medical device industries for an energizing evening of conversation, connection, and community.
Whether you are fully remote, hybrid, or somewhere in between, this event is your chance to meet peers face-to-face, share insights, and explore what the future of work looks like in life sciences. No panels, no pitches—just great people, engaging discussions, and a chance to build relationships that last beyond the Wi-Fi signal.
Expect good company, light refreshments, and a few surprises—let’s reconnect and reimagine what is next, together. |
|
Meet, Connect, and Grow: BioNTX Talent Network for Job Seekers August 20 - 21, 2025 |
|
|
The BioNTX Talent Network Meet & Greet is an opportunity for life science professionals and job seekers to connect, share industry insights, and build relationships that support career growth. Attendees will have the chance to network with peers and meet representatives from Catapult Solutions Group, a staffing firm dedicated to helping you navigate your job search and advance your career. |
|
Thank you for your support |
|
|
MEMBER SPOTLIGHT |
|
Revolutionizing Infection Treatment: Solenic Medical Unveils Breakthrough for Implant Care |
|
|
Solenic Medical Inc. is a medical device company pioneering innovative solutions to combat implant-related infections. Leveraging its proprietary targeted electromagnetic field technology, Solenic aims to revolutionize the treatment of infections on metallic implants—such as joint replacements, without the need for invasive surgery. Based in Addison, the company is advancing a non-invasive, antibiotic-free approach that holds promise for improving patient outcomes and reducing healthcare costs. |
|
MEMBER NEWS |
|
NemaLife Launches BioSēq™ Transcriptomics Platform to Uncover Mechanisms Behind Nutritional Bioactives |
|
|
NemaLife Inc., an AI-driven platform company advancing functional ingredient discovery, has announced the launch of BioSēq™, a next-generation transcriptomics platform that maps the molecular fingerprint of nutritional bioactives to human health outcomes. This launch follows the successful debut of the Discovery Flywheel™, NemaLife’s in vivo phenotypic screening platform covering six core health domains. |
|
Tivic Health Selects Scorpius BioManufacturing to Advance Entolimod™ Toward FDA BLA Filing |
|
|
Tivic Health® Systems, Inc. (Nasdaq: TIVC) announced it has entered into a definitive agreement with Scorpius BioManufacturing to complete GMP manufacturing validation for Entolimod™, its lead TLR5 candidate for the treatment of Acute Radiation Syndrome (ARS). This partnership marks a key step toward filing a Biologics License Application (BLA) with the U.S. Food and Drug Administration.
By leveraging Scorpius’ integrated development and manufacturing capabilities, Tivic aims to ensure a streamlined, U.S.-based supply chain and robust regulatory readiness. Entolimod™ is believed to be the only therapeutic candidate capable of preventing and treating radiation-induced damage to both hematopoietic and gastrointestinal tissues, positioning it for critical use in ARS and potential follow-on indications. |
|
Chris Lester Named President of Catapult Solutions Group |
|
|
|
Chris Lester |
|
Catapult Solutions Group, a trusted staffing and workforce solutions partner known for delivering reliable talent across industries such as IT, life sciences, healthcare, federal, and skilled trades, has named Chris Lester as its new President.
Chris Lester, who previously served as Chief Sales Officer, brings a strong track record of leadership, client partnership, and operational excellence. His deep understanding of Catapult’s mission and values positions him to lead the company into its next phase of growth. |
|
Where SMID Cap Biotech Meets Big-Cap Potential |
|
|
|
In the latest edition of US SMID Cap Biotech Beat, Morgan Stanley examines the transition of commercial-stage biotech companies from SMID to large-cap, introducing a four-lens analytical framework and a new stock selection process, while also comparing implied pipeline valuations to identify those best positioned for long-term growth. |
|
Munck Wilson Mandala Expands Life Sciences Practice |
|
|
|
Rudeina A. Baasiri, PhD, MS |
|
|
Merritt D. Westcott, MS, JD |
|
Munck Wilson Mandala has strengthened its Life Sciences Practice with the addition of IP partner Merritt Westcott and senior scientific advisor and registered patent agent Rudeina A. Baasiri, Ph.D. to its Texas team.
Westcott brings over 25 years of experience litigating complex biotech patent disputes, with deep expertise in matters involving monoclonal antibodies, biosimilars, and pharmaceuticals governed by the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA). Dr. Baasiri adds a strong scientific foundation to the team, offering technical insight across a range of biotechnology disciplines. |
|
Taconic Biosciences and The Michael J. Fox Foundation Expand Parkinson’s Research Tools |
|
|
Taconic Biosciences, in collaboration with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), has expanded access to a portfolio of genetically engineered mouse and rat models designed to advance Parkinson’s disease research. These models address key barriers in the field—such as limited access, poor reproducibility, and inadequate disease representation—by replicating hallmark features like dopaminergic neuron loss and genetic mutations in SNCA, PRKN, and LRRK2. |
|
UTA Researcher Develops Innovative Pants to Improve Heart MRI Testing |
|
|
|
Michael Nelson, PhD, MS |
|
University of Texas at Arlington researcher Michael Nelson developed patent-pending lower body negative-pressure pants to improve exercise stress tests inside MRI machines.
Normally, patients lie flat during these tests, which increases blood return to the heart and can mask true heart performance differences. Nelson’s pants simulate standing by reducing blood flow from the lower body, revealing how the heart actually functions under stress. This breakthrough technology transforms cardiac MRI and is poised to become a new standard in heart imaging. |
|
UT Dallas Researchers Explore AI to Improve Mammography Screenings |
|
|
As breast cancer rates rise and radiologists decline, UT Dallas professors Drs. Mehmet Ayvaci and Radha Mookerjee explored using AI to help flag high-risk mammogram cases faster. Their study, published in Nature Communications, found AI can assist radiologists by prioritizing cases and reducing costs, but should not replace human judgment. Using a large dataset, their models help identify which patients need further review, aiming to improve accuracy and efficiency in breast cancer detection. Ayvaci emphasizes keeping humans in the loop to ensure patient-centered care. |
|
UT Southwestern Uncovers Genetic Key to Appetite Control and Obesity |
|
|
|
Zhao Zhang, PhD |
|
Using Automated Meiotic Mapping (AMM), a tool developed at UT Southwestern, researchers led by Zhao Zhang, Ph.D., discovered that the gene Gpr45 plays a crucial role in controlling food intake. Published in Science, the study shows that mutations in Gpr45 cause obesity in mice by disrupting a signaling pathway in primary cilia of hypothalamic neurons, impairing activation of the appetite-regulating protein MC4R. This discovery could open new avenues for obesity treatments alongside existing weight-loss drugs. The AMM technique, pioneered by Nobel Laureate Bruce Beutler, allowed rapid identification of genetic mutations impacting body weight regulation. |
|
FUNDING & MENTORSHIP OPPORTUNITIES |
|
Sailor Post-Traumatic Stress Disorder (PTSD) Risk Prediction Model Application due June 20, 2025 |
|
|
This Request for Project Proposals will seek to utilize a robust prediction algorithm prototype to detect a risk for PTSD within the U.S Navy. The prototype model should leverage existing data sources (e.g., Defense Manpower Data Center, Military Health System Data Repository, Defense Organizational Climate Survey), incorporate cutting-edge machine learning/artificial intelligence techniques, and prioritize ethical considerations. The goal is to provide the Navy with a deployable data-driven capability to proactively identify at-risk Sailors, facilitate timely interventions, and mitigate the impact of PTSD on individual Sailors and the Fleet. |
|
Fueling Texas' Future in Cancer Research: CPRIT Faculty Recruitment Award Applications due June 20, 2025 |
|
|
The Cancer Prevention and Research Institute of Texas (CPRIT) offers funding to help Texas institutions recruit top early-career researchers pursuing their first tenure-track faculty appointment. The award supports innovative cancer research and strengthens Texas’ leadership in prevention, treatment, and discovery—particularly in priority areas like cancer disparities, childhood cancers, hepatocellular cancer, and computational oncology. |
|
Texas Rural Woman-Owned Small Business Grant Application closes June 20, 2025 |
|
|
The purpose of this grant is to foster greater economic development activity in Rural Texas by encouraging and enabling rural woman-owned, small businesses to undertake new and innovative projects. A total of ten grants for $10,000, totaling $100,000, will be given. |
|
DoD Breast Cancer Clinical Research Extension Application closes June 27, 2025 |
|
|
The fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Clinical Research Extension Award aims to extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. Applications must address at least one of the FY25 BCRP overarching challenges, unless adequate justification for exception is provided. |
|
DoD Breast Cancer Era of Hope Scholar Award Application closes June 27, 2025 |
|
|
Supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the intent of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the Principal Investigator (PI) to go beyond conventional thinking in their field and the innovative contributions that they can make toward ending breast cancer. PIs should be exceptionally talented scientists that are among “the best and the brightest” in their field(s), have demonstrated experience forming effective partnerships and collaborations, and exhibit strong potential for future leadership in breast cancer research. Applications must address one of the FY25 BCRP overarching challenges, unless adequate justification for exception is provided. |
|
Autism Data Science Initative Application closes June 27, 2025 |
|
|
The purpose of this Research Opportunity Announcement (ROA) is to invite applications from eligible organizations to support the Autism Data Science Initiative (ADSI). ADSI will bring together diverse data resources and community members with lived experience to explore novel contributors and/or to characterize the collective contributions of numerous factors to the causation of autism spectrum disorder (ASD), hereafter referred to as autism, and their potential role in increasing the prevalence of autism. ADSI will also seek to identify how existing treatments/interventions are used and better understand their outcomes to inform the design of future clinical studies. |
|
Advancing Early-Stage Innovation in Rare Cancers Application closes July 1, 2025 |
|
|
The Fiscal Year 2025 (FY25) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) supports innovative, early-stage research ideas with the potential to generate impactful data and open new avenues for investigation. |
|
Funding Bold Ideas to Advance Duchenne Muscular Dystrophy Research Letter of Intent due July 25, 2025 |
|
|
The FY25 Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) is designed to spark bold, early-stage research with the potential to transform the landscape of Duchenne muscular dystrophy (DMD). This award supports high-risk, high-reward ideas that are conceptually innovative and could lead to groundbreaking discoveries or new research directions that significantly improve outcomes for individuals living with DMD. |
|
Fueling the Next Generation of Health Innovators Application closes March 6, 2026 |
|
|
The One Health Incubator is a dynamic partnership between the Innovation Hub and the Health Sciences Center, created to support researchers and technology startups in the life sciences sector. This collaborative platform combines institutional expertise to offer an ecosystem of incubation, mentorship, and strategic connections—tailored specifically for life science innovators.
Startups and researchers benefit from access to state-of-the-art facilities, specialized resources, and guidance from industry experts. The incubator helps accelerate the development and commercialization of innovative healthcare solutions while fostering valuable relationships with potential partners, investors, and mentors. |
|
NIH Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions Program ends January 8, 2027 |
|
|
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. |
|
iC³ SUMMIT NEWS & UPDATES |
|
Save The Date: September 2025 |
|
|
|
The iC³ Life Science Summit is an event that brings together leaders and innovators from the life sciences and healthcare sectors to discuss challenges, discover new opportunities, and drive transformation.
As we look ahead to the 2025 iC³ Life Science & Healthcare Innovation Summit, we are celebrating “10 Years and Beyond” with a focus on the cutting-edge intersection of biology, technology, and artificial intelligence (AI). This convergence is powering breakthroughs in precision medicine, biomanufacturing, and other fields shaping the future of healthcare. |
|
Dates Tuesday, September 16: 7:00am - 7:00pm Wednesday, September 17: 8:00am - 3:00pm |
|
Location Hilton Anatole 2201 N Stemmons Freeway, Dallas, TX 75207 |
|
Nominate a North Texas Life Sciences Leader for the 2025 iC³ Dennis K. Stone Award Nominations due on July 1, 2025 |
|
|
(from left to right) Kristin Lonergan, CIC of Champion Commercial Insurance and 2024 DKS recipient Jeff Keyser, PhD, RPh, JD of Renibus Therapeutics |
|
BioNTX honors individuals who have made significant contributions to the North Texas biotechnology industry through the Dennis K. Stone Award. This recognition celebrates those who have advanced life science research and inspired others to do the same.
Nominees should meet the following criteria:
|
|
Recognizing the Next Generation of Life Science & Healthcare Innovators Nominations due on July 1, 2025 |
|
BioNTX is proud to spotlight emerging leaders in life sciences and healthcare innovation through the Rising Stars program at the iC³ Summit. This program honors entrepreneurs, startups, and researchers making a significant impact.
Nominees should meet the following criteria:
|
|
Applications Now Open for the 4th Annual Tech Transfer Showcase at BioNTX's iC³ Life Science Summit Application closes on July 28, 2025 |
|
Present your groundbreaking innovations at the 4th Annual Tech Transfer Showcase during BioNTX's iC³ Life Science Summit, an exclusive platform designed to connect academic institutions from Texas, Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee with top industry leaders and investors.
This event offers a unique opportunity to highlight your most promising intellectual property, explore potential collaborations, and secure funding, all while advancing the future of life sciences and technology. |
|
INDUSTRY EVENTS |
|
Upcoming Events & Opportunities |
|
|
Presents
Accelerate Your Clinical Trials with Opportunities in Australia
Join BioNTX as we welcome a visiting Australian delegation to explore how their streamlined regulatory environment, generous R&D tax incentives, and global-quality standards make Australia a top choice for early-phase clinical trials.
June 25th | Dallas, TX |
|
|
Chronic Disease Day Healthcare and Biotech Leadership Summit
Join Good Days for their National Chronic Disease Day Luncheon Symposium at the ARPA-H Customer Experience Hub in Dallas, Texas, just as the federal government intensifies its focus on chronic illness as a national priority.
July 10th | Dallas, TX |
|
|
DFW Startup Week 2025
Join DFW Startup Week, which brings together entrepreneurs and change-makers for a week-long experience. This event is described as the largest entrepreneurial event in North Texas, where they exchange ideas, collaborate, and grow alongside the 10th largest startup ecosystem in the US.
August 3rd - 7th | Dallas, TX |
|
|
Rose Gala 2025
Join To Cure a Rose for the Rose Gala — an inspiring and unforgettable evening in support of To Cure A Rose Foundation. Set against the stunning backdrop of the Omni Barton Creek Resort, this exclusive event brings together elegance, entertainment, and purpose.
August 9th | Austin, TX |
|
|
Q3 2025 BHIANT Quarterly Meeting
Join BHIANT for their second quarterly meeting of 2025. Meet with other industry leaders and collaborate to tackle pressing challenges, redefine shared goals, and strengthen the biotech and healthcare ecosystem across North Texas.
August 19th | Dallas, TX |
|
|
Presents
2025 Talent Network Meet & Greet - Arlington
Join BioNTX for the Talent Network Meet & Greet in Arlington, where job seekers can connect with others in their field, share insights to grow their network, and meet with Catapult Solutions Group, a staffing firm that can support their job search & help advance their career journey.
August 20th | Arlington, TX |
|
|
Presents
2025 Talent Network Meet & Greet - Dallas
Join BioNTX for the Talent Network Meet & Greet in Dallas, where job seekers can connect with others in their field, share insights to grow their network, and meet with Catapult Solutions Group, a staffing firm that can support their job search & help advance their career journey.
August 21st | Dallas, TX |
|
|
2025 iC³ Life Science & Healthcare Innovation Summit
The annual iC³ Life Science Summit serves as North Texas’ premier platform for the bioscience community, uniting industry and academic leaders to discuss breakthrough research, share insights, and connect over cutting-edge technologies shaping the future of healthcare.
September 16th - 17th | Dallas, TX |
|
Thank you for your Membership & Support! "In nature, nothing exists alone." - Rachel Carlson |
|
|
June 16, 2025 |
|
